Nachrichten zur Pfizer Inc. Aktie

Pfizer to invest more than $2.5 billion to expand European manufacturing

...By Michael Erman NEW YORK (Reuters) - Pfizer Inc is investing... Supply Officer Mike McDermott told Reuters. "If…

Pfizer to invest more than $2.5 bln to expand European manufacturing

... medicines over 1-1/2 years By Michael Erman NEW YORK, Dec 2 (Reuters... pipeline," Pfizer Chief Global Supply Officer Mike McDermott told Reuters......…

Pfizer to boost biological drug production with $1.26B investment in Ireland

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Pfizer to invest over $1.26 billion in Dublin manufacturing site

...(Adds details on facility, expansion plans) Dec 1 (Reuters) - Pfizer......…

Roivant Forms New Vant With Pfizer To Develop PF-06480605 For Inflammation Diseases

NEW YORK CITY (dpa-AFX) - Roivant Sciences (ROIV) and Pfizer Inc. (PFE) Thursday announced formation of a new Vant to…

Pfizer to invest over $1.26 billion in Dublin manufacturing site

...Dec 1 (Reuters) - Pfizer Inc said on Thursday it plans to invest more......…

Pfizer, Roivant launch subsidiary focused on ulcerative colitis

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Roivant, Pfizer launch unit to develop inflammatory disease drug

...(Adds details, share price) Dec 1 (Reuters) - Roivant Sciences......…

Roivant, Pfizer form company to develop ulcerative colitis treatment

Roivant Sciences and Pfizer Inc. said Thursday that they created a new company focused on developing and commercializing…

Roivant, Pfizer create unit for inflammatory disease drug

...(Reuters) - Roivant Sciences and Pfizer Inc on Thursday announced......…

Pfizer, Valneva Lyme disease vaccine shows antibodies even 6-month after vaccination

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Valneva, Pfizer Report 6-Month Antibody Persistence Data For Lyme Disease Vaccine Candidate

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Valneva SE (VALN) reported Thursday six-month antibody persistence data for Lyme…

Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate

New York & Saint-Herblain (France), December 1, 2022 – Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris:…

Valuation and Dividend Safety Analysis: Pfizer (PFE)

Here is a valuation and dividend safety analysis of Pfizer stock....…

USD 93.34 Billion Growth is expected in Drug Intermediates and APIs Market by 2026 | 1,200+ Sourcing and Procurement Report | SpendEdge

Drug Intermediates and APIs Market Report highlights the effect of COVID-19 on this market. Pfizer, Merck & Co., and Sanofi.…

Immutep Shares Rise 8% After Merck KGaA, Pfizer Collaboration on Urothelial Cancer Treatment

Immutep Shares Rise 8% After Merck KGaA, Pfizer Collaboration on Urothelial Cancer Treatment...…

United States Pharmaceutical Industry Industry Report 2022 Featuring Abbot Laboratories, AbbVie, Allergan, Amgen, BMS, Eli Lilly and Co, Gilead Sciences, GSK, Johnson & Johnson, Merck, Pfizer, & Teva

DUBLIN, Nov. 29, 2022 /PRNewswire/ -- The "Pharmaceutical Industry in the United States 2022" report has been added to ResearchAndMarkets.coms…

Pfizer, Merck KGaA join Immutep in Phase 1 trial for kidney cancer therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

3 Reasons Pfizer Stock Will Crush the Broader Market in 2023

Pfizers revenue growth is far from over....…

Immutep (ASX:IMM) enters second collaboration with Pfizer and Merck KGaA for INSIGHT study

Immutep (IMM) signs another collaboration agreement with Merck KGaA, Darmstadt, Germany and…...…

Pfizer CEO Blasted By UK Pharma Watchdog For "Disgracefully Misleading" Statements On COVID Vaccine

Pfizer CEO Blasted By UK Pharma Watchdog For "Disgracefully Misleading" Statements On COVID Vaccine …

IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline

Former Senior Vice President and Head of Early Oncology Development and Clinical Research at Pfizer will lead IDEAYAs clinical development…

Another Study Finds Heart Inflammation Higher After Moderna Vaccination Versus Pfizer

Another Study Finds Heart Inflammation Higher After Moderna Vaccination Versus Pfizer …

Joe Rosenberg on Why Alphabet and Pfizer Look Like Buys

In his long career, Rosenberg has made some prescient calls on stocks....…

"Amnesty Begins Next Week": Musk To Reinstate Suspended Twitter Accounts En Masse

"Amnesty Begins Next Week": Musk To Reinstate Suspended Twitter Accounts En Masse …

‘Died Suddenly’: The documentary on the adverse effects of the Covid vaccines released

By César Mendez The documentary film “Died Suddenly”, which chronicles the major adverse effects reported in the last two years…

Digestive Health Supplements Global Market Report 2022: Ukraine-Russia War Impact

NEW YORK, Nov. 23, 2022 /PRNewswire/ -- Major players in the digestive health supplements market are Amway Corp, Bayer AG,…

World Clinical Trials Racial Representation Data Study 2022 Featuring Novartis, GSK, Pfizer, Johnson & Johnson, AstraZeneca, F. Hoffmann-La Roche, Eli Lilly, Merck & Co, AbbVie, & Bayer

DUBLIN, Nov. 23, 2022 /PRNewswire/ -- The "Clinical Trials - The Importance of Diversity in Clinical Trials" report has been…

Pfizer Outperform

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Bank Credit Suisse hat Pfizer mit "Outperform" und einem Kursziel von 55 US-Dollar in…

ANALYSE-FLASH: Credit Suisse startet Pfizer mit 'Outperform' - Ziel 55 Dollar

ZÜRICH (dpa-AFX) - Die Schweizer Bank Credit Suisse hat Pfizer mit "Outperform" und einem Kursziel…

California Workers Win $125,000 After Vaccine Discrimination Lawsuit

California Workers Win $125,000 After Vaccine Discrimination Lawsuit Authored…

Japan approves COVID antiviral pill as Pfizer, Merck alternative

Japan approved an antiviral pill from Shionogi & Co. to treat Covid-19 after the company provided new data to show…

BioNTech-Aktie: Winkt hier ein großer Kurstreiber?

Die BioNTech-Aktie (WKN: A2PSR2) hat in den Korrekturmodus geschaltet und am Montag um -4,8% auf 158,41 US$ nachgegeben. Das ist…

Insights on the Narcolepsy Therapeutics Global Market to 2028 - Featuring Jazz Pharmaceuticals, Pfizer, Bioprojet and Takeda Pharmaceutical Among Others

DUBLIN, Nov. 21, 2022 /PRNewswire/ -- The "Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type,…

Pfizer (PFE), BioNTech Provide New Data on BA.4/BA.5 Boosters

Pfizer (PFE) and BioNTechs (BNTX) Omicron BA.4/BA.5-adapted bivalent vaccines show improved immune response against newer Omicron sublineages....…

Pfizer: Ersteinschätzung

Zürich (www.aktiencheck.de) - Rating-Update: Trung Huynh, Analyst der Credit Suisse, nimmt die Coverage für die Aktie von Pfizer Inc. (ISIN: US7170811035,…

2 Reasons to Buy Pfizer and 1 Reason to Sell

The pharmaceutical company is looking for a future beyond COVID-19 therapies....…

New Pfizer-BioNTech Covid Vaccine Is More Effective Than The Original, Study Shows

Pfizer-BioNTechs new bivalent Covid-19 vaccine—which targets the original strain and some Omicron subvariants—provides more protection against the virus and its…

Pfizer says omicron booster is better against new subvariants like BQ.1.1 than old shots

Pfizer said the booster triggered more antibodies against omicron BQ.1.1, BA.4.6, BA.2.75.2 and XBB.1 in adults older than 55 compared…

Pfizer booster spurs immune response to new omicron subtypes

Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though its not an…

BioNTech: Eine ganze Reihe positiver News - Aktienanalyse

Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…

BioNTech: Neue Daten, nächste Zulassung

Am Freitag haben die Biotech-Schmiede BioNTech und sein amerikanischer Partner Pfizer weitere Daten zum an Omikron angepassten Covid-19-Impfstoff vorgelegt. Darüber…

Pfizer, BioNTech Omicron BA.4/BA.5 bivalent booster shot shows response vs emerging subvariants

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biontech: Omikron-Booster wirksam gegen Variante BQ.1.1

- Der Impfstoff von Biontech und Pfizer für die Omikron-Variante des Coronavirus wirkt auch gegen die Untervariante BQ.1.1....…

Pfizer and BioNTech say bivalent booster increases neutralizing antibodies against new omicron variants

Pfizer Inc. and German partner BioNTech SE said Friday a new analysis of data reviewing the immune response…

UPDATE 1-Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 subvariant

...(Adds background on variant) Nov 18 (Reuters) - Pfizer Inc and its......…

Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 in older adults

...(Reuters) - Pfizer Inc and its German partner BioNTech SE said......…

Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages

NEW YORK and MAINZ, GERMANY, NOVEMBER 18, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

AMCP Foundation Interns Delve into Oncology, Evidence Gaps, Medication Adherence in Partnership with AbbVie Inc. and Pfizer Inc.

ALEXANDRIA, Va., Nov. 17, 2022 /PRNewswire/ -- AMCP Foundation congratulates the student pharmacists who recently completed immersive managed care centered…

dpa-AFX ProFeed